Twist Bioscience Expands Clonal Gene Offering with Long, Complex Sequences

Twist Bioscience (NASDAQ:TWST) has expanded its clonal gene portfolio to include longer and more complex DNA sequences through a new offering called 'Complex Genes.' The update allows the company to handle up to 7,000 base pairs with high acceptance rates for orders. This advancement supports AI-driven drug discovery and nucleic acid therapeutics.

By Fatima Gulzar Sat, May 23, 2026 at 7:50 AM GMT+3 1 min read · Yahoo Finance · May 23, 2026, 04:50 UTC

Tickers: $TWST

Topics: biotechnology DNA synthesis genetics

Read the full article at Yahoo Finance

More Business news

Acre NY Realty Announces Groundbreaking for New Residential Development in Long Island City PR Newswire · November 12, 2026, 13:44 UTC
Clever Real Estate Reaches $250 Million in Cumulative Savings Milestone for Home Sellers PR Newswire · November 12, 2026, 13:41 UTC
Anthropic Announces Initial Public Offering Scheduled for November 19 The Verge · November 12, 2026, 13:37 UTC
Caregiving Costs Rise 59% Since 2021, Driving Significant Financial Stress for Employees PR Newswire · November 12, 2026, 13:04 UTC
Redfin Report: U.S. Home Prices and Mortgage Payments Decline for Four Consecutive Weeks PR Newswire · November 12, 2026, 13:00 UTC
Broe Real Estate Group Acquires Luxury Maple Terrace Residences in Dallas PR Newswire · November 12, 2026, 13:00 UTC
Rising Income Gap Between Renting and Buying Drives Surge in Single-Family Rental Demand PR Newswire · November 12, 2026, 13:00 UTC
Mill Creek Residential Begins Move-Ins at Modera Ridgeline in McKinney, Texas PR Newswire · November 12, 2026, 12:30 UTC
U.S. Housing Market Shifts Toward Buyers as Seller's Markets Shrink to Historic Lows PR Newswire · November 12, 2026, 12:30 UTC
Asia-Pacific Region Captures 60% of Global Stablecoin Payments PR Newswire · November 12, 2026, 12:00 UTC